Sign in

JOHNSON & JOHNSON

JNJ

Share price not shown yet: live market data is not connected. Everything below comes from JNJ’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Rule of 40
31%
rev growth + FCF margin
Revenue growth
+8.1%
TTM vs prior TTM
FCF margin
22.7%
ROE (TTM)
25.7%
TTM NI ÷ avg equity
Net debt
$30.3B
total debt − cash & ST inv.
Dilution (YoY)
+0.1%
negative = buybacks
SBC / revenue
1.4%
TTM revenue
$97.9B

Revenue

$0B$5B$10B$15B$20B$25BJan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’26$25B

EPS (diluted)

$0.00$2.00$4.00$6.00$8.00$10.00Jan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’26$2.27

Gross

65%70%75%80%85%Jan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’2668%

Net income

$0B$10B$20BJan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’26$6B

Net margin

0%50%100%Jan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’2622%

Free cash flow vs. stock-based comp

FCFSBC
$0B$2B$4B$6B$8BJan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’26$7B

Operating cash flow vs. capex

OCFCapex
$0B$2B$4B$6B$8BJan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’26$9B

R&D vs. SG&A

R&DSG&A
-$10B-$5B$0B$5BJan ’22Oct ’22Jul ’23Mar ’24Dec ’24Sep ’25Jun ’26$4B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…